Title:
NANOPARTICLE SYSTEMS
Document Type and Number:
WIPO Patent Application WO/2019/140318
Kind Code:
A1
Abstract:
The present disclosure provides nanoparticle compositions in which individual nanoparticles comprise payloads and coating agents, as well as methods of making and using such nanoparticle compositions, and various compositions and/or technologies relating to such nanoparticle compositions, their production, and/or their use.
Inventors:
SOSIN HOWARD B (US)
CAPLAN MICHAEL J (US)
PRUD'HOMME ROBERT K (US)
KASTANTIN MARK (US)
DOWER APRIL (US)
DAHL SPENCER (US)
CAPLAN MICHAEL J (US)
PRUD'HOMME ROBERT K (US)
KASTANTIN MARK (US)
DOWER APRIL (US)
DAHL SPENCER (US)
Application Number:
PCT/US2019/013370
Publication Date:
July 18, 2019
Filing Date:
January 11, 2019
Export Citation:
Assignee:
N FOLD LLC (US)
International Classes:
A61K9/14; A61K9/51
Domestic Patent References:
| WO2017220615A1 | 2017-12-28 |
Foreign References:
| US20100104503A1 | 2010-04-29 | |||
| US8202540B1 | 2012-06-19 | |||
| US8187554B2 | 2012-05-29 | |||
| US20070272612A1 | 2007-11-29 | |||
| US20120231069A1 | 2012-09-13 | |||
| US20130317208A1 | 2013-11-28 | |||
| US20130183244A1 | 2013-07-18 |
Other References:
ANDERSSON, P ET AL.: "Protective Effects of the Glucocorticoid, Budesonide, on Lung Anaphylaxis in Actively Sensitized Guinea-Pigs: Inhibition of IgE-but not of IgG-Mediated Anaphylaxis", BRITISH JOURNAL OF PHARMACOLOGY, vol. 76, no. 1, May 1982 (1982-05-01), pages 139 - 147, XPP055625135
HOSHYAR N. ET AL.: "The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction", NANOMEDICINE, vol. 11, no. 6, 22 March 2016 (2016-03-22), pages 673
HOSHYAR N. ET AL.: "The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction", NANOMEDICINE, vol. 11, no. 6, 22 March 2016 (2016-03-22), pages 673
Attorney, Agent or Firm:
SMITH, Maria C. et al. (US)
Download PDF: